News headlines about Cyanotech Corporation (NASDAQ:CYAN) have trended somewhat positive recently, according to Accern Sentiment Analysis. The research group scores the sentiment of press coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Cyanotech Corporation earned a daily sentiment score of 0.18 on Accern’s scale. Accern also gave headlines about the biotechnology company an impact score of 46.6218288024686 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.

Cyanotech Corporation (NASDAQ:CYAN) opened at 4.75 on Friday. The firm’s 50-day moving average is $4.06 and its 200-day moving average is $3.84. Cyanotech Corporation has a 1-year low of $3.25 and a 1-year high of $5.35. The company’s market capitalization is $27.00 million.

Cyanotech Corporation (NASDAQ:CYAN) last announced its quarterly earnings data on Thursday, August 10th. The biotechnology company reported $0.09 earnings per share (EPS) for the quarter. The business had revenue of $8.81 million for the quarter. Cyanotech Corporation had a negative net margin of 0.07% and a negative return on equity of 0.14%. Equities research analysts predict that Cyanotech Corporation will post ($0.01) EPS for the current year.

Several research analysts have recently weighed in on the stock. TheStreet upgraded shares of Cyanotech Corporation from a “d” rating to a “c-” rating in a research note on Monday, August 28th. ValuEngine upgraded shares of Cyanotech Corporation from a “sell” rating to a “hold” rating in a research note on Monday, August 14th.

ILLEGAL ACTIVITY WARNING: “Cyanotech Corporation (CYAN) Earns Media Sentiment Rating of 0.18” was originally published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this story on another domain, it was stolen and reposted in violation of US and international trademark & copyright laws. The original version of this story can be read at

About Cyanotech Corporation

Cyanotech Corporation is engaged in the production of natural products derived from microalgae for the nutritional supplements market. The Company’s products include Hawaiian Spirulina Pacifica and Hawaiian BioAstin. Hawaiian Spirulina Pacifica is a dietary supplement used for extra energy, a strengthened immune system, cardiovascular benefits and as a source of antioxidant carotenoids.

Insider Buying and Selling by Quarter for Cyanotech Corporation (NASDAQ:CYAN)

Receive News & Stock Ratings for Cyanotech Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cyanotech Corporation and related stocks with our FREE daily email newsletter.